These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

777 related items for PubMed ID: 27997346

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis).
    Kroon FP, van der Burg LR, Ramiro S, Landewé RB, Buchbinder R, Falzon L, van der Heijde D.
    Cochrane Database Syst Rev; 2015 Jul 17; 2015(7):CD010952. PubMed ID: 26186173
    [Abstract] [Full Text] [Related]

  • 3. Comparison of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) from a single rheumatology clinic in New Delhi.
    Malaviya AN, Kalyani A, Rawat R, Gogia SB.
    Int J Rheum Dis; 2015 Sep 17; 18(7):736-41. PubMed ID: 26172961
    [Abstract] [Full Text] [Related]

  • 4. New evidence on the management of spondyloarthritis.
    Sieper J, Poddubnyy D.
    Nat Rev Rheumatol; 2016 May 17; 12(5):282-95. PubMed ID: 27052489
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1).
    Sieper J, van der Heijde D, Dougados M, Mease PJ, Maksymowych WP, Brown MA, Arora V, Pangan AL.
    Ann Rheum Dis; 2013 Jun 17; 72(6):815-22. PubMed ID: 22772328
    [Abstract] [Full Text] [Related]

  • 6. Partial remission in ankylosing spondylitis and non-radiographic axial spondyloarthritis in treatment with infliximab plus naproxen or naproxen alone: associations between partial remission and baseline disease characteristics.
    Sieper J, Rudwaleit M, Lenaerts J, Wollenhaupt J, Myasoutova L, Park SH, Song YW, Yao R, Huyck S, Govoni M, Chitkara D, Vastesaeger N.
    Rheumatology (Oxford); 2016 Nov 17; 55(11):1946-1953. PubMed ID: 27411482
    [Abstract] [Full Text] [Related]

  • 7. Brief Report: Six-Week Treatment of Axial Spondyloarthritis Patients With an Optimal Dose of Nonsteroidal Antiinflammatory Drugs: Early Response to Treatment in Signal Intensity on Magnetic Resonance Imaging of the Sacroiliac Joints.
    Varkas G, Jans L, Cypers H, Van Praet L, Carron P, Elewaut D, Van den Bosch F.
    Arthritis Rheumatol; 2016 Mar 17; 68(3):672-8. PubMed ID: 26473982
    [Abstract] [Full Text] [Related]

  • 8. Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey.
    Lopalco G, Venerito V, Cantarini L, Emmi G, Salaffi F, Di Carlo M, Tafuri S, Gentileschi S, Di Scala G, Nivuori M, Cacciapaglia F, Galeazzi M, Lapadula G, Iannone F.
    Clin Exp Rheumatol; 2019 Mar 17; 37(5):762-767. PubMed ID: 31025925
    [Abstract] [Full Text] [Related]

  • 9. Ankylosing Spondylitis versus Nonradiographic Axial Spondyloarthritis: Comparison of Tumor Necrosis Factor Inhibitor Effectiveness and Effect of HLA-B27 Status. An Observational Cohort Study from the Nationwide DANBIO Registry.
    Glintborg B, Sørensen IJ, Østergaard M, Dreyer L, Mohamoud AA, Krogh NS, Hendricks O, Andersen LS, Raun JL, Kowalski MR, Danielsen L, Pelck R, Nordin H, Pedersen JK, Kraus DG, Christensen SR, Hansen IM, Esbesen J, Schlemmer A, Loft AG, Al Chaer N, Salomonsen L, Hetland ML.
    J Rheumatol; 2017 Jan 17; 44(1):59-69. PubMed ID: 27909080
    [Abstract] [Full Text] [Related]

  • 10. Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after 1 year of treatment with etanercept: results from the ESTHER trial.
    Song IH, Weiß A, Hermann KG, Haibel H, Althoff CE, Poddubnyy D, Listing J, Lange E, Freundlich B, Rudwaleit M, Sieper J.
    Ann Rheum Dis; 2013 Jun 17; 72(6):823-5. PubMed ID: 23172749
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the nonsteroidal anti-inflammatory drug-sparing effect of etanercept in axial spondyloarthritis: results of the multicenter, randomized, double-blind, placebo-controlled SPARSE study.
    Dougados M, Wood E, Combe B, Schaeverbeke T, Miceli-Richard C, Berenbaum F, Koppiker N, Dubanchet A, Logeart I.
    Arthritis Res Ther; 2014 Nov 27; 16(6):481. PubMed ID: 25428762
    [Abstract] [Full Text] [Related]

  • 12. Procollagen I N-terminal peptide correlates with inflammation on sacroiliac joint magnetic resonance imaging in ankylosing spondylitis but not in non-radiographic axial spondyloarthritis: A cross-sectional study.
    Li X, Liang A, Chen Y, Lam NS, Long X, Xu X, Zhong S.
    Mod Rheumatol; 2022 Jul 01; 32(4):770-775. PubMed ID: 34897520
    [Abstract] [Full Text] [Related]

  • 13. Limited radiographic progression and sustained reductions in MRI inflammation in patients with axial spondyloarthritis: 4-year imaging outcomes from the RAPID-axSpA phase III randomised trial.
    van der Heijde D, Baraliakos X, Hermann KA, Landewé RBM, Machado PM, Maksymowych WP, Davies OR, de Peyrecave N, Hoepken B, Bauer L, Nurminen T, Braun J.
    Ann Rheum Dis; 2018 May 01; 77(5):699-705. PubMed ID: 29343510
    [Abstract] [Full Text] [Related]

  • 14. Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA.
    van der Heijde D, Dougados M, Landewé R, Sieper J, Maksymowych WP, Rudwaleit M, Van den Bosch F, Braun J, Mease PJ, Kivitz AJ, Walsh J, Davies O, Bauer L, Hoepken B, Peterson L, Deodhar A.
    Rheumatology (Oxford); 2017 Sep 01; 56(9):1498-1509. PubMed ID: 28498975
    [Abstract] [Full Text] [Related]

  • 15. Two-year imaging outcomes from a phase 3 randomized trial of secukinumab in patients with non-radiographic axial spondyloarthritis.
    Braun J, Blanco R, Marzo-Ortega H, Gensler LS, Van den Bosch F, Hall S, Kameda H, Poddubnyy D, van de Sande M, van der Heijde D, Zhuang T, Stefanska A, Readie A, Richards HB, Deodhar A.
    Arthritis Res Ther; 2023 May 16; 25(1):80. PubMed ID: 37194094
    [Abstract] [Full Text] [Related]

  • 16. Effects of Long-Term Etanercept Treatment on Clinical Outcomes and Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: 104-Week Results From a Randomized, Placebo-Controlled Study.
    Dougados M, van der Heijde D, Sieper J, Braun J, Citera G, Lenaerts J, van den Bosch F, Wei JC, Pedersen R, Bonin R, Jones H, Marshall L, Logeart I, Vlahos B, Bukowski JF, Maksymowych WP.
    Arthritis Care Res (Hoboken); 2017 Oct 16; 69(10):1590-1598. PubMed ID: 28482137
    [Abstract] [Full Text] [Related]

  • 17. Positive correlation between inflammation on sacroiliac joint MRI and serum C-terminal telopeptide of type-I collagen in ankylosing spondylitis but not in non-radiographic axial spondyloarthritis.
    Kang KY, Jung JY, Hong YS, Ju JH, Park SH.
    Clin Exp Rheumatol; 2017 Oct 16; 35(3):415-422. PubMed ID: 27974096
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study.
    Kilic E, Kilic G, Akgul O, Ozgocmen S.
    Rheumatol Int; 2015 Jun 16; 35(6):981-9. PubMed ID: 25366469
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.